SG Americas Securities’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.01M | Buy |
|
|||||
|
2025
Q2 | $272K | Sell |
|
|||||
|
2025
Q1 | $426K | Buy |
|
|||||
|
2024
Q4 | $392K | Sell |
|
|||||
|
2024
Q3 | $707K | Buy |
|
|||||
|
2024
Q2 | $541K | Buy |
|
|||||
|
2024
Q1 | $545K | Sell |
|
|||||
|
2023
Q4 | $562K | Buy |
|
|||||
|
2023
Q3 | $221K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $587K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $131K | Sell |
|
|||||
|
2022
Q1 | $352K | Sell |
|
|||||
|
2021
Q4 | $616K | Sell |
|
|||||
|
2021
Q3 | $765K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $235K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $359K | Buy |
|
|||||
|
2020
Q1 | $197K | Buy |
|
|||||
|
2019
Q4 | $125K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $154K | Buy |
|